5 completed. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 2 | Completed 2 |
Follow PLx Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects PL2200, Aspirin tablets - Gastroduodenal Ulceration | Phase 2 | Completed | PLx Pharma | 247 | 2012-09-01 | 2022-06-07 |
| Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults PL3100, Naproxen - Gastroduodenal Ulcerations, Erosion | Phase 2 | Completed | PLx Pharma | 77 | 2010-07-01 | 2016-04-11 |
| Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adults Naproxen, PL 3100 - Healthy Volunteers | Phase 1 / Phase 2 | Completed | PLx Pharma | 34 | 2009-08-01 | 2015-09-07 |
| Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers acetylsalicylic acid - Upper Gastrointestinal Mucosal Damage | Phase 1 / Phase 2 | Completed | PLx Pharma | 204 | 2009-01-01 | 2015-08-11 |
| Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial Ibuprofen-PC - Osteoarthritis | Phase 2 | Completed | PLx Pharma | 125 | 2005-01-01 | 2008-11-26 |
Osteoarthritis (1)
Aspirin (2) · Naproxen (2) · aspirin-phosphatidylcholine (1)
United States (4)
Alan J Kivitz, MD (1) · Byron L Cryer, MD (1) · Frank L Lanza, MD (1) · Howard Schwartz, MD (1) · Michael E Schwartz, DO (1) · Phillip B Miner, MD (1) · Upendra K. Marathi, PhD (1)
1RC3AR059535-01 (1)